Abstract:The ever-growing drug resistance problem worldwide highlights the urgency to discover and develop new drugs. Microbial natural products are a prolific source of drugs. Genome sequencing has revealed a tremendous amount of uncharacterized natural product biosynthetic gene clusters (BGCs) encoded within microbial genomes, most of which are cryptic or express at very low levels under standard culture conditions. Therefore, developing effective strategies to awaken these cryptic BGCs is of great interest for natural product discovery. In this study, we designed and validated a Transcription–Translation in One (TTO) approach for activation of cryptic BGCs. This approach aims to alter the metabolite profiles of target strains by directly overexpressing exogenous rpsL (encoding ribosomal protein S12) and rpoB (encoding RNA polymerase β subunit) genes containing beneficial mutations for natural product production using a plug-and-play plasmid system. As a result, this approach bypasses the tedious screening work and overcomes the false positive problem in the traditional ribosome engineering approach. In this work, the TTO approach was successfully applied to activating cryptic BGCs in three Streptomyces strains, leading to the discovery of two aromatic polyketide antibiotics, piloquinone and homopiloquinone. We further identified a single BGC responsible for the biosynthesis of both piloquinone and homopiloquinone, which features an unusual starter unit incorporation step. This powerful strategy can be further exploited for BGC activation in strains even beyond streptomycetes, thus facilitating natural product discovery research in the future.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00581?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00581</a>.Methods and materials, including strains, plasmids, chemicals, strain manipulation, cultivation and fermentation conditions, isolation and characterization of natural products from activated biosynthetic pathways, bioactivity assay, genome sequencing, gene overexpression and gene deletions (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00581/suppl_file/cb0c00581_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Strain Prioritization for Natural Product Discovery by a High-Throughput Real-Time PCR Method

Biosynthetic potential-based strain prioritization for natural product discovery: a showcase for diterpenoid-producing actinomycetes.

Focused Natural Product Elucidation by Prioritizing High-Throughput Metabolomic Studies with Machine Learning

Strain Prioritization and Genome Mining for Enediyne Natural Products

Targeted Genome Mining—From Compound Discovery to Biosynthetic Pathway Elucidation

Development of platensimycin, platencin, and platensilin overproducers by biosynthetic pathway engineering and fermentation medium optimization

Automated, Self-Resistance Gene-Guided, and High-Throughput Genome Mining of Bioactive Natural Products from Streptomyces

Exploring a general multi-pronged activation strategy for natural product discovery in Actinomycetes

Targeting Bacterial Genomes for Natural Product Discovery

A two-stage MS feature dereplication strategy for natural products discovery

Application of omics- and multi-omics-based techniques for natural product target discovery

Recent advances in the culture-independent discovery of natural products using metagenomic approaches

A Versatile Transcription–Translation in One Approach for Activation of Cryptic Biosynthetic Gene Clusters

High-Throughput Mining of Novel Compounds from Known Microbes: A Boost to Natural Product Screening

Recent advances in natural product discovery.

Leveraging ecological theory to guide natural product discovery

Development of a native-locus dual reporter system for the efficient screening of the hyper-production of natural products in Streptomyces

Exploiting A Precise Design Of Universal Synthetic Modular Regulatory Elements To Unlock The Microbial Natural Products In Streptomyces

The Natural Products Discovery Center: Release of the First 8490 Sequenced Strains for Exploring Actinobacteria Biosynthetic Diversity

Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information